About: Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1991

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1991 (uk) im August 1991 veröffentlichter wissenschaftlicher Artikel (de) գիտական հոդված հրատարակված 1991 թվականի օգոստոսի 1-ին (hy) artículu científicu espublizáu n'agostu de 1991 (ast) scientific article published on 01 August 1991 (en)
publication date	wds:Q68243639-03C5FFF0-CE49-4AC0-A673-BFC53F387341
publication date	1991-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68243639-5CB260F5-C105-4630-B8DA-C6C3E56DC3D3
language of work or name	English
author name string	wds:Q68243639-0AD469D0-D571-46B2-8311-7601DF11369F wds:Q68243639-0B45208E-2944-454F-AC42-7DEE36CF2444 wds:Q68243639-2306F008-7E24-4B01-BF2E-71E882577CD0 wds:Q68243639-4F3BFC2E-5ADD-4959-BD96-9B557710ABBE wds:Q68243639-630FD8DF-012A-4D4B-B9E9-EAC1D4517D9D wds:Q68243639-6D3C79E3-A268-427D-9B9B-3757805459E9 wds:Q68243639-9080EEA0-BA3E-4C47-B68E-6D64CE0F57EA wds:Q68243639-B482A3A6-8644-4119-98FC-6F05C825C885 wds:Q68243639-DBB832CD-F629-4935-9723-3E7F293375AB wds:Q68243639-DC216A5E-305A-4096-AB06-57F22487229E
author name string	J Y Ro A A Sahin T L Smith G N Hortobagyi H A Fritsche J Ro A K el-Naggar N G Ordonez A G Ayala M B Blick
rdfs:label	Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (en) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (nl)
skos:prefLabel	Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (en) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (nl)
name	Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (en) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (nl)
title	wds:Q68243639-962CE6CF-D78D-4E2C-A8C9-81A9855B17AA
title	Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis (en)
page(s)	wds:Q68243639-3FD61844-671F-45F0-B9E9-1F8E04E32F7A
page(s)	549-557
instance of	wds:Q68243639-143FCA1B-438E-4C2A-988B-46E12DC49BF1
instance of	scholarly article
PubMed ID	wds:Q68243639-023B433A-5E44-43EA-9197-D4172F9BB0A9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1648433
PubMed ID	1648433
published in	wds:Q68243639-3B55DC4B-2F33-4A2E-8CE1-BAB94C20B79F
published in	Cancer
issue	wds:Q68243639-73CAF397-AA20-420F-BE41-537EF93746DC
volume	wds:Q68243639-A69D39AF-5232-4A8A-92F2-507AE3567489
issue	3
volume	68
DOI	wds:Q68243639-BCE65846-8160-43EA-A807-6326C3061E67
DOI	http://dx.doi.org/10.1002/1097-0142(19910801)68:3%3C549::AID-CNCR2820680318%3E3.0.CO;2-J
DOI	10.1002/1097-0142(19910801)68:3<549::AID-CNCR2820680318>3.0.CO;2-J
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68243639
is cites work of	Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer Prognostic molecular markers in early breast cancer Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Ki67 in breast cancer: prognostic and predictive potential Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker? Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer MIB-1 proliferative activity in invasive breast cancer measured by image analysis. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer AgNORs in breast tumours Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia Prognostic value of proliferation in invasive breast cancer: a review Proliferation markers in tumours: interpretation and clinical value Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1 A comparative study of cell proliferation markers in breast carcinomas Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma US-guided optical tomography: correlation with clinicopathologic variables in breast cancer Serum soluble ST2 is associated with ER-positive breast cancer Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies--comparative studies on frozen and paraffin sections ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? Counting of apoptotic cells: a methodological study in invasive breast cancer Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications Cytological evaluation of biological prognostic markers from primary breast carcinomas Comparison between differentcell kinetic variables in human breast cancer Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer Guidelines for systemic therapy of early stage breast cancer Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software